The delivery of anti-tumour compounds to the colon
Ciftci, K.; Groves, M.J.
Pharmaceutical Research (New York) 11(10 Suppl): S309
1994
ISSN/ISBN: 0724-8741 Accession: 033751253
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Kiss, K.; Biri-Kovács, B.át.; Szabó, R.; Ranđelović, I.; Enyedi, K.N.ór.; Schlosser, G.; Orosz, Ád.ám.; Kapuvári, B.; Tóvári, J.óz.; Mező, G.áb. 2019: Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems European Journal of Medicinal Chemistry 176: 105-116Boualam, M.; Gielen, M.; El, K., A.; De, V., D.; Willem, R. 1995: Organo-tin compounds having anti-tumour activity and anti-tumour compositions Official Gazette of the United States Patent and Trademark Office Patents 1170(3): 1886
Dong, T.; Yi, T.; Yang, M.; Lin, S.; Li, W.; Xu, X.; Hu, J.; Jia, L.; Hong, X.; Niu, W. 2016: Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model Biochemical Journal 473(1): 7-19
Oo, C.; Snell, P.; Barrett, J.; Dorr, A.; Liu, B.; Wilding, I. 2003: Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules International Journal of Pharmaceutics 257(1-2): 297-299
Greening, D.W.; Kapp, E.A.; Ji, H.; Speed, T.P.; Simpson, R.J. 2013: Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment Biochimica et Biophysica Acta 1834(11): 2396-2407
Habets, T.H.P.M.; Oth, T.; Houben, A.W.; Huijskens, M.J.A.J.; Senden-Gijsbers, B.L.M.G.; Schnijderberg, M.C.A.; Brans, B.; Dubois, L.J.; Lambin, P.; De Saint-Hubert, M.; Germeraad, W.T.V.; Tilanus, M.G.J.; Mottaghy, F.M.; Bos, G.M.J.; Vanderlocht, J. 2016: Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response Plos one 11(7): E0159515
Marti, J.H.; Grosser, N.; Thomson, D.M. 1976: Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody International Journal of Cancer 18(1): 48-57
Zhang, C.; Huang, P.; Zhang, Y.; Chen, J.; Shentu, W.; Sun, Y.; Yang, Z.; Chen, S. 2014: Anti-tumor efficacy of ultrasonic cavitation is potentiated by concurrent delivery of anti-angiogenic drug in colon cancer Cancer Letters 347(1): 105-113
Roldo, M.; Barbu, E.; Brown, J.F.; Laight, D.W.; Smart, J.D.; Tsibouklis, J. 2007: Azo compounds in colon-specific drug delivery Expert Opinion on Drug Delivery 4(5): 547-560
Mulder, W.M.; Stukart, M.J.; Roos, M.; van Lier, R.A.; Wagstaff, J.; Scheper, R.J.; Bloemena, E. 1995: Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity Cancer Immunology Immunotherapy: Cii 41(5): 293-301
Ching, L.M.; Browne, W.L.; Tchernegovski, R.; Gregory, T.; Baguley, B.C.; Palmer, B.D. 1998: Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity British Journal of Cancer 78(3): 336-343
Kendrew, J.; Odedra, R.; Logié, A.; Taylor, P.J.; Pearsall, S.; Ogilvie, D.J.; Wedge, S.R.; Jürgensmeier, J.M. 2013: Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies Cancer ChemoTherapy and Pharmacology 71(4): 1021-1032
Xu, F.; Ye, Y.-J.; Cui, Z.-R.; Wang, S. 2005: Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer Scandinavian Journal of Immunology 61(4): 364-369
Plooy, A.C.; Lohman, P.H. 1980: Platinum compounds with anti-tumour activity Toxicology 17(2): 169-176
Ciftci, K.; Groves, M., J. 1996: Delivery of antitumor compounds to the rat colon: In vitro and in vivo evaluation International Journal of Pharmaceutics (Amsterdam) 145(1-2): 157-164